Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. - PubMed - NCBI https://t.co/vssKa46TlO
Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. - PubMed - NCBI https://t.co/eBJXi1zDLw
Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled… https://t.co/vXTfQ5Eilt
RT @cochranecollab: RT @tlassers Step down & stop? @CochraneAirways review looks at effects of reducing #LABAs in well-controlled #asthma h…
Glorious @CochraneLibrary piece on stopping LABAs in well controlled asthma patients on ICS http://t.co/dVHKIps5Tg *sounds the CPD klaxon*
Glorious @CochraneLibrary piece on stopping LABAs in well controlled asthma patients on ICS http://t.co/dVHKIps5Tg *sounds the CPD klaxon*
(COCHRANE) En un paciente con asma bien controlado con LABA + Corticoide inhalado ¿se debe suspender el LABA? http://t.co/HnvRiWrRJg
(COCHRANE) En un paciente con asma bien controlado con LABA + Corticoide inhalado ¿se debe suspender el LABA? http://t.co/HnvRiWrRJg
(COCHRANE) En un paciente con asma bien controlado con LABA + Corticoide inhalado ¿se debe suspender el LABA? http://t.co/HnvRiWrRJg
[Cochrane]"Stopping LABA may slightly reduce asthma control&QoL" Stopping LABA for adults with asthma well controlled http://t.co/UkPI28maI8
RS Cochrane de interrupción de LABA en #asma bien controlada con LABA+corticoide inhalado http://t.co/j1Z4peGfZp
RT @tlassers Step down & stop? @CochraneAirways review looks at effects of reducing #LABAs in well-controlled #asthma http://t.co/3gGh28u55b
RT @tlassers Step down & stop? @CochraneAirways review looks at effects of reducing #LABAs in well-controlled #asthma http://t.co/3gGh28u55b
RT @tlassers Step down & stop? @CochraneAirways review looks at effects of reducing #LABAs in well-controlled #asthma http://t.co/3gGh28u55b
Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled… http://t.co/FLhcqlTijo
Ne #Cochrane review: Stopping LABA for adults with asthma well controlled by LABA and ICS http://t.co/M1JeNGLkzf
Review suggests stopping LABA (while on LABA/ICS) may increase the likelihood of asthma exacerbation that require OCS http://t.co/Zmbknixvmr
Review incl. 6 RCTs, 12-24 weeks' long. 5 studies on 2781 people w/stable asthma contributed data to meta-analysis http://t.co/zmSGhMbWJt
Longer trials warranted. RCTs must include patient-important outcomes e.g. asthma control & QoL & use validated tools http://t.co/Zmbknixvmr
Step down & stop? @CochraneAirways review looks at effects of reducing LABAs in well-controlled #asthma http://t.co/qYiMB6sHdi
Thanks @KayKew, @BeckyNormansell and Shaleen for another #Cochrane Review from @StGeorgesUni. http://t.co/vLA69nwWFz
Longer trials warranted. RCTs must include patient-important outcomes e.g. asthma control & QoL & use validated tools http://t.co/Zmbknixvmr
Risk of bias across studies was generally low, and most evidence was rated as moderate quality http://t.co/ymqcrJOH5t
Review suggests stopping LABA (while on LABA/ICS) may increase the likelihood of asthma exacerbation that require OCS http://t.co/Zmbknixvmr
Risk of bias across studies was generally low, and most evidence was rated as moderate quality http://t.co/ymqcrJOH5t
Review incl. 6 RCTs, 12-24 weeks' long. 5 studies on 2781 people w/stable asthma contributed data to meta-analysis http://t.co/zmSGhMbWJt
Ne #Cochrane review: Stopping LABA for adults with asthma well controlled by LABA and ICS http://t.co/M1JeNGLkzf